{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Indacaterol&page=2", "query": { "intervention": "Indacaterol", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Indacaterol&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-23T18:17:37.292Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00900731", "title": "A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Indacaterol 150 μg", "type": "DRUG" }, { "name": "Tiotropium 18 μg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" }, { "name": "Placebo to tiotropium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1598, "start_date": "2009-06", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2011-08-19", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Phoenix, Arizona + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00900731" }, { "nct_id": "NCT01068600", "title": "Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 318, "start_date": "2010-01", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-08-19", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 54, "location_summary": "Anniston, Alabama • Jasper, Alabama • Glendale, Arizona + 46 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01068600" }, { "nct_id": "NCT01120691", "title": "Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "NVA237", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "Salbutamol/albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2224, "start_date": "2010-04", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2013-12-02", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 53, "location_summary": "Birmingham, Alabama • Fairhope, Alabama • Florence, Alabama + 46 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Florence", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01120691" }, { "nct_id": "NCT00622635", "title": "A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Indacaterol 300 μg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" }, { "name": "Salmeterol 50 μg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 68, "start_date": "2008-01", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2011-08-18", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 7, "location_summary": "Normal, Illinois • Shawnee Mission, Kansas • Lafayette, Louisiana + 4 more", "locations": [ { "city": "Normal", "state": "Illinois" }, { "city": "Shawnee Mission", "state": "Kansas" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00622635" }, { "nct_id": "NCT01156844", "title": "Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Placebo to Indacaterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 191, "start_date": "2010-03", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-08-17", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 21, "location_summary": "Anniston, Alabama • Cypress, California • Fresno, California + 16 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Cypress", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01156844" }, { "nct_id": "NCT01959412", "title": "Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol 27.5 mcg", "type": "DRUG" }, { "name": "Indacaterol 37.5", "type": "DRUG" }, { "name": "Indacaterol 55 mcg", "type": "DRUG" }, { "name": "Indacaterol 75 mcg", "type": "DRUG" }, { "name": "Indacaterol 150 mcg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 91, "start_date": "2013-11", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2015-05-06", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 12, "location_summary": "Huntington Beach, California • Los Angeles, California • Mission Viejo, California + 9 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "North Dartmouth", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01959412" }, { "nct_id": "NCT02487446", "title": "Efficacy and Safety Study of QVA149 in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "Umeclidinium/vilanterol", "type": "DRUG" }, { "name": "Placebo (umeclidinium/vilanterol)", "type": "DRUG" }, { "name": "Placebo (QVA149)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 357, "start_date": "2015-07-28", "completion_date": "2016-09-12", "has_results": true, "last_update_posted_date": "2017-12-26", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 58, "location_summary": "Andalusia, Alabama • Anniston, Alabama • Jasper, Alabama + 52 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Anniston", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Multiple Locations", "state": "Alabama" }, { "city": "Multiple Locations", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02487446" }, { "nct_id": "NCT00570778", "title": "Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "indacaterol/glycopyrrolate", "type": "DRUG" }, { "name": "indacaterol", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 154, "start_date": "2007-12", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2018-07-26", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 3, "location_summary": "St Louis, Missouri • Charlotte, North Carolina • Raleigh, North Carolina", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00570778" }, { "nct_id": "NCT00821093", "title": "Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "Indacaterol 150 µg", "type": "DRUG" }, { "name": "Salmeterol 50 µg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" }, { "name": "Placebo to salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1123, "start_date": "2009-01", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2011-08-18", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 74, "location_summary": "Anniston, Alabama • Fairhope, Alabama • Jasper, Alabama + 69 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00821093" }, { "nct_id": "NCT01727141", "title": "A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "QAB149", "type": "DRUG" }, { "name": "NVA237", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1042, "start_date": "2012-11", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2016-03-29", "last_synced_at": "2026-09-23T18:17:37.292Z", "location_count": 73, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Mesa, Arizona + 60 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01727141" } ] }